T1	Participants 115 121	autism
T2	Participants 244 250	autism
T3	Participants 268 437	Eighty-five children with autism without other medical conditions and not taking other psychotropic medications participated (ages between 3 and 12 years, mean IQ = 55).
T4	Participants 438 647	Children were grouped into trios matched by age and communication level and then randomly assigned to one of three treatment groups: biologic secretin (2 CU/kg), synthetic secretin (0.4 microg/kg), and placebo
T5	Participants 789 858	parents, teachers, and investigators, who were all blind to treatment
T6	Participants 1473 1524	children with and without gastrointestinal problems
